Cargando…
Expanding the upper age limit for cervical cancer screening: a protocol for a nationwide non-randomised intervention study
INTRODUCTION: Cervical cancer screening ceases between the ages of 60 and 65 in most countries. Yet, a relatively high proportion of cervical cancers are diagnosed in women above the screening age. This study will evaluate if screening of women aged 65–69 years may result in increased detection of c...
Autores principales: | Tranberg, Mette, Petersen, Lone Kjeld, Elfström, Klara Miriam, Hammer, Anne, Blaakær, Jan, Bennetsen, Mary Holten, Jensen, Jørgen Skov, Andersen, Berit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646343/ https://www.ncbi.nlm.nih.gov/pubmed/33154056 http://dx.doi.org/10.1136/bmjopen-2020-039636 |
Ejemplares similares
-
Value of a catch-up HPV test in women aged 65 and above: A Danish population-based nonrandomized intervention study
por: Tranberg, Mette, et al.
Publicado: (2023) -
Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program
por: Tranberg, Mette, et al.
Publicado: (2016) -
Good concordance of HPV detection between cervico-vaginal self-samples and general practitioner-collected samples using the Cobas 4800 HPV DNA test
por: Tranberg, Mette, et al.
Publicado: (2018) -
HPV self-sampling in cervical cancer screening: the effect of different invitation strategies in various socioeconomic groups – a randomized controlled trial
por: Tranberg, Mette, et al.
Publicado: (2018) -
Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial
por: Tranberg, Mette, et al.
Publicado: (2018)